Experiment 627165

Details

PropertyValue
Pharmacology
Administration routeIV
OrganismEmpty organism
CitationWITTE,RS: HSIEH,P: ELSON,P: OKEN,MM: TRUMP,DL:. (1996). A PHASE II TRIAL OF AMONAFIDE, CARACEMIDE, AND HOMOHARRINGTONINE IN THE TREATMENT OF PATIENTS WITH ADVANCED RENAL CELL CANCER.. 14(4)
Amount utilized
Compound isolated
DiseaseIN PATIENTS WITH UNRESECTABLE RENAL CARCINOMA.
Dose amount4.0 MG
Number2
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitSQ M BODY SURFACE
Dose expressionDOSE